LUNG FUNG GROUP
| Register Close | 2026/06/02 IPO Closing in 2 Days |
| Listing Date | 2026/06/05 |
| Register Close | 2026/06/02 IPO Closing in 2 Days |
| Listing Date | 2026/06/05 |
Lung Fung Group Holdings is a leading Hong Kong-based chain retail store of beauty, health and pharmaceutical products. The Group offers a wide variety of beauty products, health products, pharmaceutical products and other consumer goods such as household and daily essentials and food products, covering 11 categories, namely proprietary Chinese medicines, western medicines, health supplements, skincare, cosmetics, fragrances, personal care, maternal and infant products, food, pet food and household daily necessities.
--
According to the report, in 2025, the Group ranked third among beauty, health and pharmaceutical product retailers with a market share of 5.8% in terms of retail sales value in Hong Kong; and it was the largest pharmaceutical product retailer by retail sales value in Hong Kong, with a market share of 5.2% and also the third largest pharmaceutical and health product retailer by revenue in Hong Kong, with a market share of approximately 4.2%.
--
As at 19 May 2026, the Group operated 31 retail stores in Hong Kong under its “Lung Fung” brand with an aggregate UFA exceeding 123,000 sq.ft., covering major tourism and shopping areas, residential areas and office commercial areas.
--
As at 30 November 2025, the Group had over 600 suppliers and established over 40 private label brands. The vast majority of the Group’s customers are walk-in retail customers at its retail stores and it also sell to retail customers through its online sales platforms. The Group also supply products to corporate customers on wholesale basis, mainly trading companies and local pharmacies in Hong Kong.
| Market | Hong Kong (Main Board) |
| Business Nature | Household & Personal Products |
| Major Business Area | Hong Kong |
| Board Lot | 500 |
| No. of Offer Shares | 125.00M shares |
| No. of International Offer Shares | 112.50M shares |
| No. of HK Offer Shares | 12.50M shares |
| Offer Price | $5.18 - $6.38 |
| Stock Code | 2290 |
| Sponsor(s) | DBS Asia Capital Limited |
| Underwriter(s) | DBS Asia Capital Limited, CMB International Capital Limited, Phillip Securities (Hong Kong) Limited, SPDB International Capital Limited, uSmart Securities Limited |
| Application Period | May 28 (Thu) - noon, Jun 02 (Tue) |
| Price Determination Date | Jun 03 (Wed) |
| Result Announcement Date | On or before Jun 04 (Thu) |
| Result Announcement Date | On or before Jun 04 (Thu) |
| Result Announcement Date | On or before Jun 05 (Fri) |
| Dealings in Shares commence on | Jun 05, 2026. (Fri) |
| Offer Price | $5.18 - $6.38 |
| Capitalization | 2.59B - 3.19B |
| NAV / share ($) | $1.33 - $1.62 (Unaudited pro forma adj NAV / share) |
| Assuming the offer price being at HKD 5.78, the net proceeds raised would be HKD 672.10M, of which |
| 36.6% : Expanding, enhancing and optimising physical and online sales network |
| 3.5% : Brand management and marketing |
| 3.5% : Strengthening supply chain capability through expanding and upgrading existing procurement office and warehouse in Japan and warehouse in Korea |
| 11.4% : Upgrading and enhancing information technology systems |
| 20% : Repay outstanding loans |
| 15% : Pursue selective strategic investment and acquisition opportunities |
| 10% : Working capital |
| Prospectus |
| Remark: | The above information is referenced from the prospectus. |
| All data is calculated from the non- exercise rights(if applicable). |
| Currency | : |
| Listing Price | : |
| Board Lot | : |
| Admission Fee* |
: |
| Subscribing Lot | : |
| Subscribing Fee | : |
| Subscribing Amount | : |